United States· US:0268-8056_739911f7-038e-48f0-a424-9b2c786a6c68
MIXED RAGWEED
A medicinal product containing ambrosia artemisiifolia; ambrosia trifida pollen, registered in United States by ALK-Abello, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN
- Manufacturer
- ALK-Abello, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1102688056065.5 mL in 1 VIAL (0268-8056-06)
- ndc110268-8056-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2051930-1e7e-449a-a9e4-8f31824221e7 GET /v1/drugs/b2051930-1e7e-449a-a9e4-8f31824221e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "PERCUTANEOUS",
"source": "ndc",
"strength": ".05; .05",
"substance": "AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN",
"productndc": "0268-8056",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "g/mL; g/mL",
"application_number": "BLA103753",
"marketing_category": "BLA"
}See everything about ambrosia artemisiifolia; ambrosia trifida pollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.